BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 12191690)

  • 1. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
    Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
    Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers.
    Cirri M; Mura P; Rabasco AM; Ginés JM; Moyano JR; Gònzalez-Rodrìguez ML
    Drug Dev Ind Pharm; 2004 Jan; 30(1):65-74. PubMed ID: 15000431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers.
    Mura P; Faucci MT; Maestrelli F; Furlanetto S; Pinzauti S
    J Pharm Biomed Anal; 2002 Aug; 29(6):1015-24. PubMed ID: 12110386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
    Mura P; Faucci MT; Bettinetti GP
    Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems.
    Mura P; Faucci MT; Parrini PL; Furlanetto S; Pinzauti S
    Int J Pharm; 1999 Mar; 179(1):117-28. PubMed ID: 10053208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems.
    Mura P; Adragna E; Rabasco AM; Moyano JR; Pérez-Martìnez JI; Arias MJ; Ginés JM
    Drug Dev Ind Pharm; 1999 Mar; 25(3):279-87. PubMed ID: 10071820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.
    Mennini N; Bragagni M; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2014 Feb; 89():142-9. PubMed ID: 24291109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
    Pralhad T; Rajendrakumar K
    J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
    Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
    Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization.
    Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M
    Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state.
    Mura P; Furlanetto S; Cirri M; Maestrelli F; Corti G; Pinzauti S
    J Pharm Biomed Anal; 2005 Apr; 37(5):987-94. PubMed ID: 15862677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with beta-cyclodextrin and its sulfobutyl ether derivative in solution and solid state.
    Ribeiro LS; Ferreira DC; Veiga FJ
    Eur J Pharm Sci; 2003 Nov; 20(3):253-66. PubMed ID: 14592691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of beta-lapachone and methylated beta-cyclodextrin solid-state systems.
    Cunha-Filho MS; Dacunha-Marinho B; Torres-Labandeira JJ; Martínez-Pacheco R; Landín M
    AAPS PharmSciTech; 2007 Jul; 8(3):E60. PubMed ID: 17915810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
    Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
    Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.
    Veiga MD; Ahsan F
    Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.
    Mura P; Bettinetti GP; Cirri M; Maestrelli F; Sorrenti M; Catenacci L
    Eur J Pharm Biopharm; 2005 Jan; 59(1):99-106. PubMed ID: 15567306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.